Ovarian cancer (OC) is the second most common and the most fatal gynecologic cancer in
the United States. Over the last decade, various targeted therapeutics have been introduced …

Epithelial ovarian cancer (EOC) is the deadliest gynecological cancer, and the major cause
of death is mainly attributed to metastasis. MicroRNAs (miRNAs) are a group of small non …

Treatment of disseminated epithelial ovarian cancer (EOC) is an unmet medical need.
Therefore, the identification along with preclinical and clinical validation of new targets is an …

Ovarian cancer is one of the top gynecological malignancies that cause deaths among
females in the United States. At the molecular level, significant progress has been made in …

Epithelial ovarian cancer is the fifth most frequent cause of cancer death in women. In spite
of the advantages in early detection and treatment options, overall survival rates have …

Epithelial ovarian cancer (EOC) is a complex disease, with multiple histological subtypes
recognized. There have been major advances in the understanding of the cellular and …

Ovarian cancer is the major cause of gynecologic cancer‐related mortality. Regardless of
outstanding advances, which have been made for improving the prognosis, diagnosis, and …

Introduction: Ovarian carcinoma (OC) is the leading cause of death in women with
gynecologic cancers. Most patients are diagnosed at an advanced stage with a low five-year …

One of the most prevalent and lethal forms of gynecological cancer is ovarian cancer (OC),
which is often diagnosed in its latter, deadly stages. The OC's high mortality and …

Ovarian cancer (OC) is the most lethal of malignant gynecological cancers, and has a very
poor prognosis, frequently, attributable to late diagnosis and responsiveness to …